Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HMGCR | P04035 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6746940 | 1.00 | ALDH1A1 (0.31) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL6889572 | 1.00 | ALDH1A1 (0.31) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Water SCHEMBL9151500 | 0.98 | ALDH1A1 (0.30) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL10549264 | 0.98 | ALDH1A1 (0.30) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL221253 | 0.98 | ALDH1A1 (0.32) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL4954541 | 0.96 | ALDH1A1 (0.31) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Water SCHEMBL8376683 | 0.96 | ALDH1A1 (0.31) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Ammonia Solution, Strong SCHEMBL15653109 | 0.96 | ALDH1A1 (0.31) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Formaldehyde SCHEMBL11705917 | 0.94 | ALDH1A1 (0.30) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL1358443 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0812923-A1 | Improved method for the recovery of lead from exhausted lead acid storage batteries | Ente per le Nuove Tecnologie, l'Energia e l'Ambiente - ENEA (IT) | 1997-12-17 | — | — | EP | claimed |
| EP-0225878-A1 | MEDICINAL COMPOSITION AND METHOD FOR THE TREATMENT OF PERIARTHRITIS AND SIMILAR DISEASES | ELECTROCHEMICAL INTERNATIONAL LIMITED (GB) | 1987-06-24 | — | — | EP | claimed |
| WO-1986001719-A1 | MEDICINAL COMPOSITION AND METHOD FOR THE TREATMENT OF PERIARTHRITIS AND SIMILAR DISEASES | X-RAY HOLDING S.A. (LU) | 1986-03-27 | — | — | WO | claimed |
| WO-2014168510-A1 | METHOD FOR PRODUCING RABIES VACCINE | ФЕДЕРАЛЬНОЕ КАЗЕННОЕ ПРЕДПРИЯТИЕ "ЩЕЛКОВСКИЙ БИОКОМБИНАТ" (RU) | 2014-10-16 | — | — | WO | disclosed |
| EP-1658079-B1 | MULTIVITAMIN SYRUP FOR CHILDREN OR YOUNG ADULTS | PHARMATON SA (CH) | 2012-04-25 | — | — | EP | disclosed |
| US-8152861-B2 | Dark coloured azo dyes | THE PROCTER & GAMBLE COMPANY (US) | 2012-04-10 | — | — | US | disclosed |
| US-20110225742-A1 | Dark Coloured Azo Dyes | WELLA OPERATIONS US, LLC | 2011-09-22 | — | — | US | disclosed |
| EP-1730153-B1 | ISOPROPANOL WATER SOLVATE OF OLANZAPINE | KRKA TOVARNA ZDRAVIL D D NOVO MESTO (SI) | 2011-07-20 | — | — | EP | disclosed |
| US-7977482-B2 | Dark coloured azo dyes | THE PROCTER & GAMBLE COMPANY (US) | 2011-07-12 | — | — | US | disclosed |
| EP-1844109-B1 | USE OF CATIONIC AZACYANINE DYES FOR COLORING KERATIN FIBERS | PROCTER & GAMBLE (US) | 2011-03-30 | — | — | EP | disclosed |
| US-7906642-B2 | Isopropanol water solvate of olanzapine | KRKA, TOVARNA ZDRAVIL, D.D. (SI) | 2011-03-15 | — | — | US | disclosed |
| WO-2006081245-A1 | AGENTS FOR COLORING KERATIN FIBERS | THE PROCTER & GAMBLE COMPANY (US) | 2006-08-03 | — | — | WO | disclosed |
| WO-2005085256-A1 | ISOPROPANOL WATER SOLVATE OF OLANZAPINE | KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO (SI) | 2005-09-15 | — | — | WO | disclosed |
| US-20030157494-A1 | Smooth muscle cell promoter and uses thereof | UNIVERSITEIT MAASTRICHT (NL) | 2003-08-21 | — | — | US | disclosed |
| EP-1214439-A2 | SMOOTH MUSCLE CELL PROMOTER AND USES THEREOF | Universiteit Maastricht/Cardiovascular Research Insitute Maastricht ( Carim) (NL) | 2002-06-19 | — | — | EP | disclosed |
| WO-2001018048-A2 | SMOOTH MUSCLE CELL PROMOTER AND USES THEREOF | UNIVERSITEIT MAASTRICHT/CARDIOVASCULAR RESEARCH INSTITUTE MAASTRICHT (CARIM) (NL) | 2001-03-15 | — | — | WO | disclosed |
| EP-1083231-A1 | Smooth muscle cell promoter and uses thereof | Introgene B.V. (NL) | 2001-03-14 | — | — | EP | disclosed |
| US-5944869-A | SOLUBILIZING LEAD SULFATE AND LEAD OXIDE; REDUCTION | ENTE PER LE NUOVE TECHNOLOGIE, L'ENERGIA E L'AMBIENTE (ENEA) (IT) | 1999-08-31 | — | — | US | disclosed |
| EP-0812923-A1 | Improved method for the recovery of lead from exhausted lead acid storage batteries | Ente per le Nuove Tecnologie, l'Energia e l'Ambiente - ENEA (IT) | 1997-12-17 | — | — | EP | disclosed |
| WO-1991017469-A1 | KIT FOR CONTACT LENSES | VEPEX CONTRACTOR LTD. (HU) | 1991-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110225742-A1 | Dark Coloured Azo Dyes | KRT18, CYB5R3, CYBA | ALDH1A1 709/4885HMGCR 4063/4885CHRM1 1643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.